Stocks making the biggest moves premarket: Walmart, Coinbase, Moderna, Alibaba & more

Premarket movers were mixed: Walmart shares fell 6% despite a revenue beat, as U.S. comparable sales rose 2.6% (below the 3.5% expected) and fiscal Q3/full-year EPS guidance missed. In contrast, crypto-linked stocks rallied as Bitcoin and ether surged on Trump’s push for crypto-friendly legislation (Coinbase +~7%, Strategy +~10%, Circle +~7.5%). Alibaba slid 3.4% after a 75% profit drop tied to a 75% jump in AI-related capex, while Moderna fell 7% after its prior 177% surge on promising melanoma vaccine trial results.

Analysis

Walmart’s reaction matters less as a retail print than as a signal that “defensive” is no longer synonymous with insulated. When comp momentum slows at the low end of the market, suppliers lose pricing power first, then retailers lose operating leverage; that combination is usually worse for margin expectations than for revenue. The second-order read-through is negative for broad consumer staples and dollar-store names, while e-commerce/marketplace share-takers can still absorb share if households stay value-seeking.

Crypto-linked equities are being traded as pure policy beta, but the market is likely underpricing the gap between headline enthusiasm and actual legislation. COIN and CRCL have the cleaner operating leverage if policy clarity increases because activity and issuance volumes matter; MSTR and the smaller miners are just amplified BTC proxies and will unwind fastest if the legislative path slows or Bitcoin fails to hold its breakout. Near term this is a momentum trade; over 1-3 months it becomes a proof-of-policy trade, and the reversal risk is a Senate stall, not a price chart.

Alibaba’s spend surge is the classic “invest now, explain later” setup: near-term earnings quality deteriorates, but the real question is whether the capex creates a durable cloud/AI moat or just subsidizes competition. The market is likely to punish the margin hit before it rewards any future share gains, so the valuation risk is multiple compression if returns on that spend are not visible by the next two quarters. Nordson is the cleaner industrial read-through: guidance improvement suggests end-demand is not rolling over, which is constructive for niche capital equipment even if the broader manufacturing tape stays choppy.

Key Decisions for Investors

• Short WMT on any bounce over the next 1-2 sessions; thesis is that a slower comp trajectory compresses the premium multiple and pressures supplier pricing. Falsify if management re-accelerates traffic or raises guidance on the next readthrough.
• Pair trade: long COIN / short MSTR for a 1-3 month horizon. COIN has cleaner sensitivity to higher volume and policy clarity; MSTR is higher-beta BTC leverage and should underperform if policy headlines fade or BTC retraces.
• Buy NDSN on pullbacks or add vs. an industrial basket (IYJ/XLI) over 3-6 months. Guidance upside suggests a better order environment than the market has priced, with lower downside than broad cyclicals if manufacturing stays soft.
• Sell rallies in BABA or use put spreads for a 1-3 month window. The near-term market will punish capex-driven margin dilution unless the company can show cloud/AI monetization inflecting quickly; cover if the stock reclaims the post-print gap and management tightens ROIC commentary.
• No chase on MRNA after the rerate; wait for filing/regulatory milestones before adding risk. If implied volatility stays elevated, consider selling upside call spreads rather than buying outright until the commercial path becomes clearer.